 This study is being conducted to compare the safety and effectiveness of the investigational medication, LdT Telbivudine with Lamivudine, a drug currently approved by the US, European and Asian Health Authorities for the treatment of hepatitis B infection. The results for patients taking LdT will be compared to results for patients taking Lamivudine. 